This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Asahi Kasei Kabushiki Kaisha. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Soyeun Yang: Innovator in Hyaluronic Acid Derivative Compositions
Introduction
Soyeun Yang is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work with hyaluronic acid derivatives. His research and inventions have the potential to impact various medical applications.
Latest Patents
Soyeun Yang holds 1 patent for a hyaluronic acid derivative composition, which includes a pharmaceutical composition and a hyaluronic acid derivative-drug conjugate composition. This invention provides a hyaluronic acid derivative composition that comprises a hyaluronic acid derivative with a steryl group and a polar group-containing compound. The steryl group is introduced at a specific ratio, enhancing the composition's effectiveness. The pharmaceutical composition utilizes this derivative as a carrier, while the conjugate composition allows for the attachment of one or more drugs to the hyaluronic acid derivative.
Career Highlights
Soyeun Yang is currently employed at Asahi Kasei Kabushiki Kaisha, where he continues to develop innovative solutions in the pharmaceutical field. His work is characterized by a commitment to advancing medical technology and improving patient outcomes.
Collaborations
Soyeun has collaborated with notable colleagues, including Kohei Yabuuchi and Keisuke Fukumoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Soyeun Yang's contributions to the field of hyaluronic acid derivatives exemplify the importance of innovation in pharmaceuticals. His work not only showcases his expertise but also highlights the potential for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile